查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1848873

内视镜再处理市场（依服务模式、装置类型、最终用户、应用程式和产品）－2025-2032 年全球预测

Endoscope Reprocessing Market by Service Model, Device Type, End User, Application, Product - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 180 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年内视镜再处理市场将成长至 70.8 亿美元，复合年增长率为 9.39%。

主要市场统计数据
基准年2024年 34.5亿美元
预计2025年 37.7亿美元
预测年份：2032年 70.8亿美元
复合年增长率（%） 9.39%

内视镜再处理是一个简洁的方向，它为临床安全、操作复杂性和影响仪器净化和仪器生命週期管理的策略重点提供了一个框架。

内视镜再处理是临床安全、监管严谨性和营运效率的交会点。医疗机构和服务供应商必须管理复杂的器材库存，同时确保进入护理路径的每支软式内视镜或硬式内视镜均不含生物污染物，并透过经过验证的流程进行追溯。近年来，由于对感染传播、器械复杂性和交叉污染风险的担忧，再处理已从幕后操作升级为一项策略性的病患安全措施，促使医院和门诊中心重新审视其工作流程、器械选择和供应商关係。

因此，医疗保健领导者优先考虑能够减少差异性、加快週转时间并证明符合不断发展的标准的投资。自动化再处理设备、彻底的干燥和储存解决方案以及对耗材化学品的技术需求如今与营运限制（例如员工技能差距和高处理容量要求）并存。相关人员面临着一个多方面的问题，需要在临床结果、工作流程弹性和营运总成本之间取得平衡。为了应对这些压力，决策者需要明确的标准来评估技术、服务模式和通讯协定，以便在不影响产能或增加员工负担的情况下提高净化可靠性。

本介绍将探讨整个分析过程中反覆出现的核心主题：设备复杂性、监管期望、劳动力能力以及支援服务交付同时保护病患安全的可追溯和检验流程的需求。

分析自动化、日益严格的监管和不断发展的服务模式如何重新定义内视镜再处理的实践标准、合规期望和技术采用

内视镜再处理领域正在经历一系列变革时期，这得益于日趋成熟的技术、日益强化的监管环境以及不断发展的服务交付模式。自动化和设备的进步正在减少人工操作的差异性，并透过一致的验证文件实现更高的处理量，从而重塑了人们对週转时间和人员配置模式的预期。同时，软式内视镜（尤其是那些具有复杂通道和升降装置的内视镜）的复杂性，使得人们对再处理化学品和机械清洁步骤的有效性越来越严格，这促使製造商和服务供应商围绕特定于设备的通讯协定进行创新。

监管和认证机构正在加强可追溯性、设备验证和员工能力的标准，从而提升数位文件和流程监控在日常营运中的作用。因此，医疗服务供应商和集中式无菌处理设施越来越受欢迎，但这种转变也增加了对稳健供应链和透明服务水准协议的需求。

生命週期影响、废弃物管理以及一次性和可重复使用器械之间的平衡影响着采购和临床指南。这些趋同趋势正在加速创新，同时也迫使组织采用更严格、系统化的再处理管治方法。

重点检视关税波动和贸易政策变化如何影响采购选择、供应连续性以及后处理设备和消耗品的生命週期成本

关税调整和贸易政策变化对整个后处理设备及配件供应链中的设备采购、耗材定价和供应商选择策略产生了实际的影响。资本设备、替换零件和化学耗材的关税变化可能会增加采购成本，改变关键零件的前置作业时间，并促使买家重新评估其供应商多元化策略。为此，采购团队正在进行细緻的成本服务分析，并对供应合约进行压力测试，以确保服务的连续性并持续符合灭菌和清洁要求。

这些贸易动态通常会促进设备製造商、区域经销商和医疗系统采购团体之间更紧密的合作，以减轻进口相关成本波动的影响。一些医疗保健机构正在透过谈判长期合约、在当地储备常用耗材或寻找合格的替代供应商来维持营运韧性。同时，自动化再处理设备和辅助设备的开发人员正在调整其产品蓝图、零件采购计划和售后支援模式，以降低关税导致的成本上涨对其造成的脆弱性。

累积效应是，人们更重视全生命週期筹资策略，这些策略应考虑跨国成本压力，同时保障临床绩效和供应的连续性。因此，营运领导者必须将价格情境规划纳入资本投资决策和耗材采购中，以避免后处理工作流程出现意外中断。

全面的细分主导观点，将服务模式、设备类别、临床环境、程序应用和产品系列与营运和采购优先事项连结起来

細項分析揭示了服务模式、设备分类、最终用户环境、临床用途和产品类别如何共同塑造采购优先事项和营运工作流程。透过服务模式评估，组织可以区分内部维护无菌处理或外包给第三方服务供应商。软式内视镜（例如软式内视镜、大肠镜、十二指肠镜、胃镜和输尿管镜）通常需要复杂的通道清洁和有效的化学处理，而硬式内视镜（例如关节镜、膀胱镜和腹腔镜）往往具有不同的清洁网路基地台和再处理週期曲线。

门诊手术中心、诊所、诊断中心和医院在吞吐量、病例组合和监管义务方面差异很大。应用主导的细分突出了胃肠内视镜、腹腔镜、呼吸系统医疗设备和泌尿系统等手术领域，每个领域都有独特的仪器使用模式和感染预防敏感性，这些都会影响再处理技术和消耗品化学的选择。产品级细分区分资本设备、消耗品和配件。资本设备包括自动内视镜再处理器、干燥柜和灭菌器，它们推动製程验证和设施布局，而消耗品和配件包括清洁剂、酵素清洁剂、润滑剂和灭菌配件，它们推动日常操作实践。

综合起来，这些层面创建了一个多维市场地图，突出显示了创新和投资可以提供最大运营槓桿的地方，以及需要定制培训、验证通讯协定和服务协议来支持安全高效的仪器再利用的地方。

透过对美洲、欧洲、中东和非洲以及亚太地区的采用驱动因素、监管预期和供应链动态进行区域分析，揭示了此次推出的战略意义

区域动态对技术采用模式、监管预期和供应商生态系统有重大影响。在美洲，医疗保健系统优先考虑遵守国家感染预防标准、快速采用自动化技术，并更加重视集中无菌处理，以提高整个医院网路的运作效率。供应链应对力以及与製造商和经销商的接近性通常会影响资本备件和高使用率耗材的库存策略，而区域监管指导则会影响验证和文件记录实践。

跨多个司法管辖区的监管协调、不同的报销模式以及对生命週期环境影响的日益关注推动了欧洲、中东和非洲独特的采购和使用模式，而跨境供应商关係可能会受到区域贸易协定和物流限制的影响。

在亚太地区，医疗保健基础设施的快速扩张、三级医疗机构投资的不断增加以及监管成熟度的差异，共同创造了一个碎片化但成熟的创新环境。该地区的买家通常优先考虑扩充性的自动化和劳动力发展解决方案，以适应不断增长的诊疗量；而製造商和服务供应商调整其产品功能和支援模式，以适应多样化的设施类型和区域服务交付限制。在各个地区，当地监管指南、采购框架以及合格服务合作伙伴的可用性仍然是组织选择后处理技术和耗材组合的决定性因素。

策略性地描述领先供应商如何将硬体、耗材和数位可追溯性融入整合、有效的工作流程和服务模式，以满足买家的需求

再处理生态系统中的主要企业专注于整合解决方案，这些解决方案将经过检验的资本设备、耗材化学品和数位可追溯性相结合，以在安全性和製程控制方面实现可衡量的改进。公司的策略重点包括提高再处理週期的自动化程度，增强针对复杂内视镜的设备专用清洁通讯协定，以及扩展服务范围，例如託管再处理和集中灭菌，以捕捉生命週期价值。设备製造商与第三方服务机构之间的伙伴关係日益普遍，因此能够提供捆绑服务，简化医疗保健系统的采购和营运。

创新管道专注于易用性、与医疗机构IT系统的互通性以及可靠的检验数据，以支援合规性并增强买家信心。耗材製造商正在改进酵素製剂和润滑剂，以提高清洁效率并减少製程波动；而干燥柜和灭菌器製造商则专注于循环记录和材料相容性。此外，随着医院寻求可靠的培训计划和响应迅速的技术支持，以保持产能并最大限度地减少停机时间，售后和教育服务也日益成为差异化因素。

竞争正从分散的产品功能转向全面、可支援的工作流程，从而降低临床团队的风险和管理负担。因此，能够实现硬体、软体和耗材无缝集成，并拥有响应式服务模式的主要企业，将在设施品质和可追溯性至关重要的市场中主导地位。

为决策者提供切实可行的优先行动，将自动化、劳动力能力、采购弹性和数位可追溯性整合成一个连贯的再处理策略，以降低风险。

产业领导者应采取一系列协调一致的倡议，将技术应用与营运管治和员工能力结合。优先投资自动化和检验的资本设备，减少人工差异，并创建一致的流程文檔，以支援认证和审核准备。在设备升级的同时，应为无菌处理人员制定严格的能力培养计划，利用基于模拟的培训和熟练程度指标来巩固最佳实践，并减少再处理错误。

实现关键耗材供应商多元化，以缓解供应链中断，同时透过协商服务等级协议（包括承诺快速提供零件、预防性保养和培训）来加强与供应商的关係。实施与电子健康记录和资产管理平台整合的数位可追溯系统，以捕获设备历史记录、再处理週期和维护记录，从而加快根本原因分析和监管报告。评估集中式或第三方再处理的机会，这些机会可以透过规模效率提高吞吐量和标准化程度，但要确保合约明确规定品管指标和流程透明度。

最后，为了平衡临床有效性和永续性目标，应将环境和生命週期评估纳入采购决策，并维持主动的监管监督计划，以预测不断变化的标准。透过协调资本、耗材、培训和数据策略，领导者可以建立具有韧性且合规的再处理运营，从而既保障病患安全，又提升营运绩效。

混合方法调查方法的透明概述，结合专家访谈、技术咨询和二次分析，检验在不同领域获得经过验证且可操作的发现

这种研究途径将结构化的一手资料研究与专家意见以及严谨的二次分析相结合，从而产生可靠且可操作的资讯库。主要方法包括与无菌处理经理、临床负责人、采购专家和第三方服务业者进行深入访谈，以了解实际操作限制、技术评估标准和采购驱动因素。这些定性资讯与产品工程师和验证专家的技术咨询相辅相成，以详细说明特定器械的再处理挑战和器械性能属性。

二次分析利用已发布的监管指南、临床最佳实践文件、产品文献和案例研究来绘製技术特性和流程要求。数据三角测量将访谈洞察与产品规格和已记录的标准进行匹配，以识别一致的模式和差异。我们应用了跨服务模式、产品类型、最终用户环境、临床应用和产品类别的细分框架，以确保研究结果与清晰的决策背景相关。

我们的调查方法和资料来源强调假设的透明度、资料来源的可追溯性，以及诸如司法管辖区监管差异和工具设计演变等限制。在适当的情况下，我们进行了敏感性检验，以检验我们的策略建议在其他营运情境下是否有效。这种结构化方法确保我们的建议是基于从业人员的经验、技术细节和交叉检验的证据。

简洁的综合框架将后处理作为系统级优先事项，其中对设备、消耗品、培训和可追溯性的协调投资将带来安全性和弹性的显着改善

内视镜再处理不再只是一项幕后技术功能，而是现代医疗服务中以合规主导的策略要素。投资经过检验的自动化系统、强大的耗材化学流程以及全面的员工能力提升专案的机构，能够更好地管理感染风险、维持产能并证明合规性。区域和贸易动态持续影响筹资策略，使供应链弹性和供应商协作成为长期营运规划的重要组成部分。

当组织将再处理视为一个端到端系统时，最有效的改进就会发生：资本设备、耗材、数位可追溯性、员工培训和服务伙伴关係关係必须协调一致，才能产生可重复、审核的结果。行业参与者——製造商、服务供应商和医疗系统——正在透过开发强调互通性、记录和检验的工作流程的整合产品来应对这一挑战。展望未来，领导者必须在眼前的商业利益与永续性以及对不断发展的设备设计和监管预期的适应性之间取得平衡。

最终，成功取决于采用系统观点，优先考虑病患安全、流程可靠性和采购弹性。将此观点融入采购、人员配备和品质框架，有助于实现临床疗效和营运稳定性的持久提升。

目录

第一章：前言

第二章调查方法

第三章执行摘要

第四章 市场概况

第五章 市场洞察

  • 广泛采用整合数位可追溯性和合规性文件的自动化内视镜再处理系统
  • 一次性内视镜的需求激增，以最大限度地降低交叉污染的风险并消除手动清洁步骤
  • 开发和引入快速起效、低毒性的高效消毒剂，以缩短再处理工作流程的週期时间
  • 实施人工智慧驱动的检查和通道完整性分析工具，主动检测内视镜缺陷并制定维护计划
  • 为了防止内视镜通道内形成生物膜，引入了具有控制气流和湿度的先进干燥柜。
  • 扩展后处理作业的综合服务合同，包括设备维护、製程检验和员工培训
  • 日益增多的法规将推动内视镜生命週期管理采用标准化通讯协定和数位记录
  • 整合即时监控软体平台，提供内视镜再处理週期关键参数的远端分析和警报
  • 内视镜原始设备製造商与医疗保健提供者之间的策略伙伴关係开发了针对临床需求的客製化再处理解决方案
  • 采用环保消毒剂、水循环利用和节能设备设计的永续再处理实践变得越来越重要。

第六章：2025年美国关税的累积影响

第七章：人工智慧的累积影响，2025年

8. 内视镜再处理市场（依服务模式）

  • 内部
  • 第三者

9. 内视镜再处理市场（依设备类型）

  • 灵活的
    • 支气管镜检查
    • 大肠镜检查
    • 十二指肠镜
    • 胃镜
    • 输尿管镜
  • 死板的
    • 关节镜
    • 膀胱镜
    • 腹腔镜

第 10 章内视镜再处理市场（依最终用户）

  • 门诊手术中心
  • 诊所
  • 诊断中心
  • 医院

第11章内视镜再处理市场（依应用）

  • 胃肠内视镜检查
  • 腹腔镜检查
  • 呼吸系统医疗设备
  • 泌尿系统

第十二章内视镜再处理市场（依产品）

  • 资本设备
    • 内视镜自动再处理装置
    • 干燥柜
    • 消毒器
  • 耗材及配件
    • 清洁剂
    • 酵素清洁剂
    • 润滑剂
    • 灭菌配件

第十三章内视镜再处理市场（按地区）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章内视镜再处理市场（依类别）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章 内视镜再处理市场（依国家）

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章竞争格局

  • 2024年市占率分析
  • 2024年FPNV定位矩阵
  • 竞争分析
    • Olympus Corporation
    • HOYA Corporation
    • Fujifilm Holdings Corporation
    • STERIS plc
    • Getinge AB
    • Ecolab Inc.
    • 3M Company
    • Karl Storz SE & Co. KG
    • Belimed AG
    • Scil Technology Ltd
Product Code: MRR-50124643627B

The Endoscope Reprocessing Market is projected to grow by USD 7.08 billion at a CAGR of 9.39% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 3.45 billion
Estimated Year [2025] USD 3.77 billion
Forecast Year [2032] USD 7.08 billion
CAGR (%) 9.39%

A concise orientation to endoscope reprocessing that frames clinical safety imperatives, operational complexity, and the strategic priorities shaping instrument decontamination and device lifecycle management

Endoscope reprocessing sits at the intersection of clinical safety, regulatory rigor, and operational efficiency. Healthcare facilities and service providers must manage complex instrument inventories while ensuring that each flexible or rigid endoscope introduced into care pathways is free of biological contaminants and traceable through validated processes. In recent years, concerns about infection transmission, device complexity, and cross-contamination risks have elevated reprocessing from a back-of-house activity to a strategic patient-safety imperative, prompting hospitals and ambulatory centers to re-examine workflows, equipment selection, and supplier relationships.

Consequently, healthcare leaders are prioritizing investments that reduce variability, shorten turnaround times, and deliver demonstrable compliance with evolving standards. The technical demands of automated reprocessors, thorough drying and storage solutions, and consumable chemistries now coexist with operational constraints such as staff skill gaps and high throughput requirements. Stakeholders face a multifaceted problem set where clinical outcomes, workflow resilience, and total cost of operation must be balanced. To navigate these pressures, decision-makers require clear criteria to evaluate technologies, service models, and protocols that improve decontamination reliability without compromising capacity or increasing staff burden.

This introduction frames the core themes that recur throughout the analysis: device complexity, regulatory expectations, workforce capability, and the imperative for traceable, validated processes that uphold patient safety while supporting service delivery.

An analysis of how automation, regulatory reinforcement, and service model evolution are redefining operational standards, compliance expectations, and technology adoption across endoscope reprocessing

The landscape of endoscope reprocessing is undergoing a series of transformative shifts driven by technology maturation, heightened regulatory scrutiny, and evolving service delivery paradigms. Automation and instrumentation advances are reducing manual variability and enabling higher throughput with consistent validation records, which in turn reshape expectations for turnaround time and staffing models. Simultaneously, the complexity of flexible endoscopes-especially those with intricate channels and elevator mechanisms-has increased scrutiny on the effectiveness of reprocessing chemistries and mechanical cleaning steps, prompting both manufacturers and service providers to innovate around device-specific protocols.

Regulatory bodies and accreditation organizations are reinforcing standards for traceability, device validation, and staff competency, which has elevated the role of digital documentation and process monitoring in routine operations. As a result, providers are integrating information systems that capture device histories, maintenance records, and reprocessing logs to demonstrate compliance and enable root-cause analysis when incidents occur. Third-party service providers and centralized sterile processing units are gaining traction as health systems seek scale efficiencies, but this shift also increases the need for robust supply chains and transparent service-level agreements.

Finally, sustainability and single-use debate are introducing new vectors of decision-making: lifecycle impacts, waste management, and the balance between disposables and reusable equipment influence procurement and clinical guidelines. These converging trends are accelerating innovation while compelling organizations to adopt more rigorous, system-level approaches to reprocessing governance

A focused review of how tariff changes and trade policy shifts are influencing procurement choices, supply continuity, and lifecycle cost considerations for reprocessing equipment and consumables

Tariff adjustments and trade policy shifts have tangible effects on equipment sourcing, consumable pricing, and vendor selection strategies across the supply chain for reprocessing equipment and accessories. Changes in duties on capital equipment, replacement parts, and chemical consumables can increase procurement costs, alter lead times for critical components, and prompt buyers to re-evaluate supplier diversification strategies. In response, procurement teams are conducting granular cost-to-serve analyses and stress-testing supply agreements to ensure continuity of service and maintain compliance with sterilization and cleaning requirements.

These trade dynamics often catalyze closer collaboration between device manufacturers, regional distributors, and health system purchasing groups to mitigate exposure to import-related cost volatility. Some organizations are responding by negotiating longer-term contracts, localizing inventories of high-use consumables, or qualifying alternative suppliers to preserve operational resilience. At the same time, developers of automated reprocessors and ancillary capital equipment are adjusting product roadmaps, component sourcing plans, and aftermarket support models to reduce vulnerability to tariff-induced cost increases.

The cumulative effect is a heightened focus on total lifecycle procurement strategies that account for cross-border cost pressures while safeguarding clinical performance and supply continuity. Operational leaders should therefore integrate tariff scenario planning into capital investment decisions and consumables sourcing to avoid unexpected disruptions to reprocessing workflows

A comprehensive segmentation-driven perspective linking service models, device classes, clinical settings, procedural applications, and product families to operational and procurement priorities

Segmentation analysis reveals how service model, device taxonomy, end-user environment, clinical application, and product class combine to shape procurement priorities and operational workflows. When evaluating by service model, organizations distinguish between maintaining in-house sterile processing versus outsourcing to third-party service providers, each approach presenting different demands for capital investment, staffing, and quality oversight. Examining device type highlights the divergent requirements of flexible and rigid endoscopes: flexible instruments include bronchoscope, colonoscope, duodenoscope, gastroscope, and ureteroscope variants that often require intricate channel cleaning and validated chemistries, while rigid instruments such as arthroscope, cystoscope, and laparoscope tend to have different cleaning access points and reprocessing cycle profiles.

End-user considerations further refine priorities across ambulatory surgical centers, clinics, diagnostic centers, and hospitals, where throughput, case mix, and regulatory obligations vary significantly. Application-driven segmentation indicates procedural domains-gastrointestinal endoscopy, laparoscopy, pulmonology, and urology-each with specific device usage patterns and infection-prevention sensitivities that influence selection of reprocessing techniques and consumable chemistries. Product-level segmentation distinguishes capital equipment from consumables and accessories: capital items include automated endoscope reprocessors, drying cabinets, and sterilizers that anchor process validation and facility layout, while consumables and accessories encompass detergents, enzymatic cleaners, lubricants, and sterilization accessories that determine daily operating practice.

Taken together, these strata form a multidimensional market map that clarifies where innovation and investment deliver the most operational leverage, and where tailored training, validation protocols, and service contracts are required to support safe, efficient instrument reuse.

A regional analysis that contrasts adoption drivers, regulatory expectations, and supply chain dynamics across the Americas, Europe Middle East & Africa, and Asia-Pacific to reveal strategic implications for deployment

Regional dynamics materially influence technology adoption patterns, regulatory expectations, and supplier ecosystems. In the Americas, health systems emphasize compliance with national infection-prevention standards, rapid technology adoption for automation, and growing interest in centralized sterile processing to drive operational efficiencies across hospital networks. Supply chain responsiveness and proximity to manufacturers or distributors often shape stocking strategies for capital spare parts and high-use consumables, while regional regulatory guidance informs validation and documentation practices.

In Europe, Middle East & Africa, regulatory harmonization across multiple jurisdictions, varying reimbursement models, and a heightened focus on lifecycle environmental impacts drive distinct procurement and usage patterns. Facilities frequently weigh environmental considerations alongside clinical effectiveness when assessing single-use versus reusable components, and cross-border supplier relationships can be influenced by regional trade agreements and logistical constraints.

In Asia-Pacific, rapid healthcare infrastructure expansion, increasing investments in tertiary care capacity, and varied regulatory maturity levels produce a fragmented but innovation-ready environment. Buyers in this region often prioritize scalable automation and workforce training solutions to meet growing procedural volumes, while manufacturers and service providers adapt product features and support models to accommodate diverse facility types and regional service delivery constraints. Across all regions, local regulatory guidance, procurement frameworks, and the availability of qualified service partners remain decisive factors when organizations select reprocessing technologies and consumable portfolios

A strategic account of how leading suppliers are converging hardware, consumables, and digital traceability into integrated validated workflows and service models to meet purchaser demands

Leading firms in the reprocessing ecosystem are concentrating on integrated solutions that combine validated capital equipment, consumable chemistries, and digital traceability to deliver measurable improvements in safety and process control. Strategic priorities for companies include advancing automation in reprocessing cycles, enhancing device-specific cleaning protocols for complex endoscopes, and expanding service offerings such as managed reprocessing and centralized sterilization to capture lifecycle value. Partnerships between equipment manufacturers and third-party service organizations are increasingly common, enabling bundled offerings that simplify procurement and operation for health systems.

Innovation pipelines emphasize ease-of-use, interoperability with facility IT systems, and robust validation data to support regulatory compliance and purchaser confidence. Consumable manufacturers are refining enzymatic formulations and lubricants to improve cleaning efficacy and reduce process variability, while makers of drying cabinets and sterilizers focus on cycle documentation and material compatibility. Additionally, aftermarket support and education services have become a differentiator, as hospitals demand reliable training programs and rapid technical assistance to maintain throughput and minimize downtime.

Competition is shifting from discrete product features toward comprehensive, validated workflows that reduce risk and administrative burden for clinical teams. As a result, companies that can demonstrate seamless integration of hardware, software, and consumables alongside responsive service models are positioned to lead in markets where institutional quality and traceability are non-negotiable

Practical and prioritized actions for decision-makers to align automation, workforce competency, procurement resilience, and digital traceability into a cohesive reprocessing strategy that reduces risk

Industry leaders should pursue a coordinated set of initiatives that align technology adoption with operational governance and workforce capability. Prioritize investments in automation and validated capital equipment to reduce manual variability and generate consistent process documentation that supports accreditation and audit readiness. Complement equipment upgrades with rigorous competency programs for sterile processing staff, leveraging simulation-based training and proficiency metrics to embed best practices and reduce reprocessing errors.

Strengthen supplier relationships by negotiating service-level agreements that include rapid parts availability, preventive maintenance, and training commitments, while diversifying sources for critical consumables to mitigate supply-chain disruptions. Implement digital traceability systems that integrate with electronic health records and asset management platforms to capture device histories, reprocessing cycles, and maintenance records, enabling faster root-cause analysis and regulatory reporting. Evaluate opportunities for centralized or third-party reprocessing where scale efficiencies can improve throughput and standardization, but ensure contracts specify quality control metrics and transparency in processes.

Finally, incorporate environmental and lifecycle assessments into procurement decisions to balance clinical efficacy with sustainability objectives, and maintain an active program for regulatory surveillance to anticipate standard changes. By aligning capital, consumables, training, and data strategies, leaders can build resilient, compliant reprocessing operations that support both patient safety and operational performance

A transparent overview of the mixed-method research approach combining expert interviews, technical consultations, and secondary analysis to ensure validated and actionable findings across discrete segments

The research approach combines structured primary engagement with domain experts and disciplined secondary analysis to generate a reliable, actionable intelligence base. Primary methods include in-depth interviews with sterile processing managers, clinical leads, procurement specialists, and third-party service operators to capture real-world operational constraints, technology evaluation criteria, and procurement drivers. These qualitative inputs are complemented by technical consultations with product engineers and validation specialists to detail device-specific reprocessing challenges and equipment performance attributes.

Secondary analysis leverages publicly available regulatory guidance, clinical best-practice documents, product literature, and case studies to map technology features and process requirements. Data triangulation reconciles interview insights with product specifications and documented standards to identify consistent patterns and areas of divergence. Segmentation frameworks were applied across service model, device type, end-user setting, clinical application, and product class to ensure that findings are relevant to distinct decision contexts.

The methodology emphasizes transparency in assumptions, traceability of data sources, and limitations such as jurisdictional variability in regulation and the evolving nature of device designs. Where appropriate, sensitivity checks were performed to validate that strategic recommendations hold under alternate operational scenarios. This structured approach ensures recommendations are grounded in practitioner experience, technical detail, and cross-validated evidence

A concise synthesis that frames reprocessing as a systems-level priority where aligned investments in equipment, consumables, training, and traceability yield measurable improvements in safety and resilience

Endoscope reprocessing is no longer solely a technical backroom function but a strategic, compliance-driven component of modern healthcare delivery. Facilities that invest in validated automation, robust consumable chemistries, and comprehensive staff competency programs are better positioned to control infection risk, maintain throughput, and demonstrate regulatory compliance. Regional and trade dynamics continue to shape procurement strategies, making supply-chain resilience and supplier collaboration essential elements of long-term operational planning.

The most impactful improvements arise when organizations treat reprocessing as an end-to-end system: capital equipment, consumables, digital traceability, workforce training, and service partnerships must be aligned to produce repeatable, auditable outcomes. Industry participants-manufacturers, service providers, and health systems-are responding by developing integrated offerings that emphasize interoperability, documentation, and validated workflows. Moving forward, leaders will need to balance immediate operational gains with considerations for sustainability and adaptability to evolving device designs and regulatory expectations.

Ultimately, success depends on adopting a systems perspective that prioritizes patient safety, process reliability, and procurement resilience. Those who embed this perspective into purchasing, staffing, and quality frameworks will realize sustained benefits in clinical outcomes and operational stability

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Widespread adoption of automated endoscope reprocessor systems integrated with digital traceability and compliance documentation
  • 5.2. Surge in demand for single-use disposable endoscopes to minimize cross-contamination risks and eliminate manual cleaning steps
  • 5.3. Development and market introduction of fast-acting, low-toxicity high-level disinfectants reducing cycle times in reprocessing workflows
  • 5.4. Implementation of AI-driven inspection and channel integrity analysis tools for proactive endoscope defect detection and maintenance planning
  • 5.5. Deployment of advanced drying cabinets with controlled airflow and humidity to prevent biofilm formation in endoscope channels
  • 5.6. Expansion of comprehensive service agreements including equipment maintenance, process validation, and staff training for reprocessing operations
  • 5.7. Heightened regulatory scrutiny driving adoption of standardized protocols and digital record-keeping for endoscope lifecycle management
  • 5.8. Integration of real-time monitoring software platforms providing remote analytics and alerts for key parameters in endoscope reprocessing cycles
  • 5.9. Strategic partnerships between endoscope OEMs and healthcare providers to develop customized reprocessing solutions tailored to clinical needs
  • 5.10. Growing emphasis on sustainable reprocessing practices with eco-friendly disinfectants, water recycling, and energy-efficient equipment designs

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Endoscope Reprocessing Market, by Service Model

  • 8.1. In-House
  • 8.2. Third Party

9. Endoscope Reprocessing Market, by Device Type

  • 9.1. Flexible
    • 9.1.1. Bronchoscope
    • 9.1.2. Colonoscope
    • 9.1.3. Duodenoscope
    • 9.1.4. Gastroscope
    • 9.1.5. Ureteroscope
  • 9.2. Rigid
    • 9.2.1. Arthroscope
    • 9.2.2. Cystoscope
    • 9.2.3. Laparoscope

10. Endoscope Reprocessing Market, by End User

  • 10.1. Ambulatory Surgical Center
  • 10.2. Clinic
  • 10.3. Diagnostic Center
  • 10.4. Hospitals

11. Endoscope Reprocessing Market, by Application

  • 11.1. Gastrointestinal Endoscopy
  • 11.2. Laparoscopy
  • 11.3. Pulmonology
  • 11.4. Urology

12. Endoscope Reprocessing Market, by Product

  • 12.1. Capital Equipment
    • 12.1.1. Automated Endoscope Reprocessors
    • 12.1.2. Drying Cabinets
    • 12.1.3. Sterilizers
  • 12.2. Consumables And Accessories
    • 12.2.1. Detergents
    • 12.2.2. Enzymatic Cleaners
    • 12.2.3. Lubricants
    • 12.2.4. Sterilization Accessories

13. Endoscope Reprocessing Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Endoscope Reprocessing Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Endoscope Reprocessing Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. Olympus Corporation
    • 16.3.2. HOYA Corporation
    • 16.3.3. Fujifilm Holdings Corporation
    • 16.3.4. STERIS plc
    • 16.3.5. Getinge AB
    • 16.3.6. Ecolab Inc.
    • 16.3.7. 3M Company
    • 16.3.8. Karl Storz SE & Co. KG
    • 16.3.9. Belimed AG
    • 16.3.10. Scil Technology Ltd

LIST OF FIGURES

  • FIGURE 1. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY SERVICE MODEL, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY SERVICE MODEL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY DEVICE TYPE, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY DEVICE TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY PRODUCT, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY PRODUCT, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS ENDOSCOPE REPROCESSING MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA ENDOSCOPE REPROCESSING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA ENDOSCOPE REPROCESSING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPE REPROCESSING MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE ENDOSCOPE REPROCESSING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST ENDOSCOPE REPROCESSING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA ENDOSCOPE REPROCESSING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC ENDOSCOPE REPROCESSING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN ENDOSCOPE REPROCESSING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC ENDOSCOPE REPROCESSING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION ENDOSCOPE REPROCESSING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS ENDOSCOPE REPROCESSING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 ENDOSCOPE REPROCESSING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO ENDOSCOPE REPROCESSING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. ENDOSCOPE REPROCESSING MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. ENDOSCOPE REPROCESSING MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. ENDOSCOPE REPROCESSING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY SERVICE MODEL, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY SERVICE MODEL, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY IN-HOUSE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY IN-HOUSE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY IN-HOUSE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY IN-HOUSE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY IN-HOUSE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY IN-HOUSE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY THIRD PARTY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY THIRD PARTY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY THIRD PARTY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY THIRD PARTY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY THIRD PARTY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY THIRD PARTY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY FLEXIBLE, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY FLEXIBLE, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY FLEXIBLE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY FLEXIBLE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY FLEXIBLE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY FLEXIBLE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY FLEXIBLE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY FLEXIBLE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY BRONCHOSCOPE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY BRONCHOSCOPE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY BRONCHOSCOPE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY BRONCHOSCOPE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY BRONCHOSCOPE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY BRONCHOSCOPE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY COLONOSCOPE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY COLONOSCOPE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY COLONOSCOPE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY COLONOSCOPE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY COLONOSCOPE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY COLONOSCOPE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY DUODENOSCOPE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY DUODENOSCOPE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY DUODENOSCOPE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY DUODENOSCOPE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY DUODENOSCOPE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY DUODENOSCOPE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY GASTROSCOPE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY GASTROSCOPE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY GASTROSCOPE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY GASTROSCOPE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY GASTROSCOPE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY GASTROSCOPE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY URETEROSCOPE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY URETEROSCOPE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY URETEROSCOPE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY URETEROSCOPE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY URETEROSCOPE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY URETEROSCOPE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY RIGID, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY RIGID, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY RIGID, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY RIGID, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY RIGID, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY RIGID, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY RIGID, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY RIGID, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY ARTHROSCOPE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY ARTHROSCOPE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY ARTHROSCOPE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY ARTHROSCOPE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY ARTHROSCOPE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY ARTHROSCOPE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY CYSTOSCOPE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY CYSTOSCOPE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY CYSTOSCOPE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY CYSTOSCOPE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY CYSTOSCOPE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY CYSTOSCOPE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY LAPAROSCOPE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY LAPAROSCOPE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY LAPAROSCOPE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY LAPAROSCOPE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY LAPAROSCOPE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY LAPAROSCOPE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY CLINIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY CLINIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY CLINIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY CLINIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY CLINIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY CLINIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY DIAGNOSTIC CENTER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY DIAGNOSTIC CENTER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY DIAGNOSTIC CENTER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY DIAGNOSTIC CENTER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY DIAGNOSTIC CENTER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY DIAGNOSTIC CENTER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY LAPAROSCOPY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY LAPAROSCOPY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY LAPAROSCOPY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY LAPAROSCOPY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY LAPAROSCOPY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY LAPAROSCOPY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY PULMONOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY PULMONOLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY PULMONOLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY PULMONOLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY PULMONOLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY PULMONOLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY UROLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY UROLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY UROLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY UROLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY UROLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY UROLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY CAPITAL EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY CAPITAL EQUIPMENT, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY CAPITAL EQUIPMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY CAPITAL EQUIPMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY CAPITAL EQUIPMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY CAPITAL EQUIPMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY CAPITAL EQUIPMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY CAPITAL EQUIPMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY AUTOMATED ENDOSCOPE REPROCESSORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY AUTOMATED ENDOSCOPE REPROCESSORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY AUTOMATED ENDOSCOPE REPROCESSORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY AUTOMATED ENDOSCOPE REPROCESSORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY AUTOMATED ENDOSCOPE REPROCESSORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY AUTOMATED ENDOSCOPE REPROCESSORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY DRYING CABINETS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY DRYING CABINETS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY DRYING CABINETS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY DRYING CABINETS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY DRYING CABINETS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY DRYING CABINETS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY STERILIZERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY STERILIZERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY STERILIZERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY STERILIZERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY STERILIZERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY STERILIZERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY CONSUMABLES AND ACCESSORIES, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY CONSUMABLES AND ACCESSORIES, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY CONSUMABLES AND ACCESSORIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY CONSUMABLES AND ACCESSORIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY CONSUMABLES AND ACCESSORIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY CONSUMABLES AND ACCESSORIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY CONSUMABLES AND ACCESSORIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY CONSUMABLES AND ACCESSORIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY DETERGENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY DETERGENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY DETERGENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY DETERGENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY DETERGENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY DETERGENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY ENZYMATIC CLEANERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY ENZYMATIC CLEANERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY ENZYMATIC CLEANERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY ENZYMATIC CLEANERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY ENZYMATIC CLEANERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY ENZYMATIC CLEANERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY LUBRICANTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY LUBRICANTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY LUBRICANTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY LUBRICANTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY LUBRICANTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY LUBRICANTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY STERILIZATION ACCESSORIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY STERILIZATION ACCESSORIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY STERILIZATION ACCESSORIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY STERILIZATION ACCESSORIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY STERILIZATION ACCESSORIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY STERILIZATION ACCESSORIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 199. AMERICAS ENDOSCOPE REPROCESSING MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 200. AMERICAS ENDOSCOPE REPROCESSING MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 201. AMERICAS ENDOSCOPE REPROCESSING MARKET SIZE, BY SERVICE MODEL, 2018-2024 (USD MILLION)
  • TABLE 202. AMERICAS ENDOSCOPE REPROCESSING MARKET SIZE, BY SERVICE MODEL, 2025-2032 (USD MILLION)
  • TABLE 203. AMERICAS ENDOSCOPE REPROCESSING MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 204. AMERICAS ENDOSCOPE REPROCESSING MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 205. AMERICAS ENDOSCOPE REPROCESSING MARKET SIZE, BY FLEXIBLE, 2018-2024 (USD MILLION)
  • TABLE 206. AMERICAS ENDOSCOPE REPROCESSING MARKET SIZE, BY FLEXIBLE, 2025-2032 (USD MILLION)
  • TABLE 207. AMERICAS ENDOSCOPE REPROCESSING MARKET SIZE, BY RIGID, 2018-2024 (USD MILLION)
  • TABLE 208. AMERICAS ENDOSCOPE REPROCESSING MARKET SIZE, BY RIGID, 2025-2032 (USD MILLION)
  • TABLE 209. AMERICAS ENDOSCOPE REPROCESSING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 210. AMERICAS ENDOSCOPE REPROCESSING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 211. AMERICAS ENDOSCOPE REPROCESSING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 212. AMERICAS ENDOSCOPE REPROCESSING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 213. AMERICAS ENDOSCOPE REPROCESSING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 214. AMERICAS ENDOSCOPE REPROCESSING MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 215. AMERICAS ENDOSCOPE REPROCESSING MARKET SIZE, BY CAPITAL EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 216. AMERICAS ENDOSCOPE REPROCESSING MARKET SIZE, BY CAPITAL EQUIPMENT, 2025-2032 (USD MILLION)
  • TABLE 217. AMERICAS ENDOSCOPE REPROCESSING MARKET SIZE, BY CONSUMABLES AND ACCESSORIES, 2018-2024 (USD MILLION)
  • TABLE 218. AMERICAS ENDOSCOPE REPROCESSING MARKET SIZE, BY CONSUMABLES AND ACCESSORIES, 2025-2032 (USD MILLION)
  • TABLE 219. NORTH AMERICA ENDOSCOPE REPROCESSING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 220. NORTH AMERICA ENDOSCOPE REPROCESSING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 221. NORTH AMERICA ENDOSCOPE REPROCESSING MARKET SIZE, BY SERVICE MODEL, 2018-2024 (USD MILLION)
  • TABLE 222. NORTH AMERICA ENDOSCOPE REPROCESSING MARKET SIZE, BY SERVICE MODEL, 2025-2032 (USD MILLION)
  • TABLE 223. NORTH AMERICA ENDOSCOPE REPROCESSING MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 224. NORTH AMERICA ENDOSCOPE REPROCESSING MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 225. NORTH AMERICA ENDOSCOPE REPROCESSING MARKET SIZE, BY FLEXIBLE, 2018-2024 (USD MILLION)
  • TABLE 226. NORTH AMERICA ENDOSCOPE REPROCESSING MARKET SIZE, BY FLEXIBLE, 2025-2032 (USD MILLION)
  • TABLE 227. NORTH AMERICA ENDOSCOPE REPROCESSING MARKET SIZE, BY RIGID, 2018-2024 (USD MILLION)
  • TABLE 228. NORTH AMERICA ENDOSCOPE REPROCESSING MARKET SIZE, BY RIGID, 2025-2032 (USD MILLION)
  • TABLE 229. NORTH AMERICA ENDOSCOPE REPROCESSING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 230. NORTH AMERICA ENDOSCOPE REPROCESSING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 231. NORTH AMERICA ENDOSCOPE REPROCESSING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 232. NORTH AMERICA ENDOSCOPE REPROCESSING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 233. NORTH AMERICA ENDOSCOPE REPROCESSING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 234. NORTH AMERICA ENDOSCOPE REPROCESSING MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 235. NORTH AMERICA ENDOSCOPE REPROCESSING MARKET SIZE, BY CAPITAL EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 236. NORTH AMERICA ENDOSCOPE REPROCESSING MARKET SIZE, BY CAPITAL EQUIPMENT, 2025-2032 (USD MILLION)
  • TABLE 237. NORTH AMERICA ENDOSCOPE REPROCESSING MARKET SIZE, BY CONSUMABLES AND ACCESSORIES, 2018-2024 (USD MILLION)
  • TABLE 238. NORTH AMERICA ENDOSCOPE REPROCESSING MARKET SIZE, BY CONSUMABLES AND ACCESSORIES, 2025-2032 (USD MILLION)
  • TABLE 239. LATIN AMERICA ENDOSCOPE REPROCESSING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 240. LATIN AMERICA ENDOSCOPE REPROCESSING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 241. LATIN AMERICA ENDOSCOPE REPROCESSING MARKET SIZE, BY SERVICE MODEL, 2018-2024 (USD MILLION)
  • TABLE 242. LATIN AMERICA ENDOSCOPE REPROCESSING MARKET SIZE, BY SERVICE MODEL, 2025-2032 (USD MILLION)
  • TABLE 243. LATIN AMERICA ENDOSCOPE REPROCESSING MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 244. LATIN AMERICA ENDOSCOPE REPROCESSING MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 245. LATIN AMERICA ENDOSCOPE REPROCESSING MARKET SIZE, BY FLEXIBLE, 2018-2024 (USD MILLION)
  • TABLE 246. LATIN AMERICA ENDOSCOPE REPROCESSING MARKET SIZE, BY FLEXIBLE, 2025-2032 (USD MILLION)
  • TABLE 247. LATIN AMERICA ENDOSCOPE REPROCESSING MARKET SIZE, BY RIGID, 2018-2024 (USD MILLION)
  • TABLE 248. LATIN AMERICA ENDOSCOPE REPROCESSING MARKET SIZE, BY RIGID, 2025-2032 (USD MILLION)
  • TABLE 249. LATIN AMERICA ENDOSCOPE REPROCESSING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 250. LATIN AMERICA ENDOSCOPE REPROCESSING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 251. LATIN AMERICA ENDOSCOPE REPROCESSING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 252. LATIN AMERICA ENDOSCOPE REPROCESSING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 253. LATIN AMERICA ENDOSCOPE REPROCESSING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 254. LATIN AMERICA ENDOSCOPE REPROCESSING MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 255. LATIN AMERICA ENDOSCOPE REPROCESSING MARKET SIZE, BY CAPITAL EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 256. LATIN AMERICA ENDOSCOPE REPROCESSING MARKET SIZE, BY CAPITAL EQUIPMENT, 2025-2032 (USD MILLION)
  • TABLE 257. LATIN AMERICA ENDOSCOPE REPROCESSING MARKET SIZE, BY CONSUMABLES AND ACCESSORIES, 2018-2024 (USD MILLION)
  • TABLE 258. LATIN AMERICA ENDOSCOPE REPROCESSING MARKET SIZE, BY CONSUMABLES AND ACCESSORIES, 2025-2032 (USD MILLION)
  • TABLE 259. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPE REPROCESSING MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 260. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPE REPROCESSING MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 261. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPE REPROCESSING MARKET SIZE, BY SERVICE MODEL, 2018-2024 (USD MILLION)
  • TABLE 262. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPE REPROCESSING MARKET SIZE, BY SERVICE MODEL, 2025-2032 (USD MILLION)
  • TABLE 263. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPE REPROCESSING MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 264. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPE REPROCESSING MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 265. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPE REPROCESSING MARKET SIZE, BY FLEXIBLE, 2018-2024 (USD MILLION)
  • TABLE 266. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPE REPROCESSING MARKET SIZE, BY FLEXIBLE, 2025-2032 (USD MILLION)
  • TABLE 267. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPE REPROCESSING MARKET SIZE, BY RIGID, 2018-2024 (USD MILLION)
  • TABLE 268. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPE REPROCESSING MARKET SIZE, BY RIGID, 2025-2032 (USD MILLION)
  • TABLE 269. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPE REPROCESSING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 270. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPE REPROCESSING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 271. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPE REPROCESSING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 272. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPE REPROCESSING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 273. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPE REPROCESSING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 274. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPE REPROCESSING MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 275. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPE REPROCESSING MARKET SIZE, BY CAPITAL EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 276. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPE REPROCESSING MARKET SIZE, BY CAPITAL EQUIPMENT, 2025-2032 (USD MILLION)
  • TABLE 277. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPE REPROCESSING MARKET SIZE, BY CONSUMABLES AND ACCESSORIES, 2018-2024 (USD MILLION)
  • TABLE 278. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPE REPROCESSING MARKET SIZE, BY CONSUMABLES AND ACCESSORIES, 2025-2032 (USD MILLION)
  • TABLE 279. EUROPE ENDOSCOPE REPROCESSING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 280. EUROPE ENDOSCOPE REPROCESSING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 281. EUROPE ENDOSCOPE REPROCESSING MARKET SIZE, BY SERVICE MODEL, 2018-2024 (USD MILLION)
  • TABLE 282. EUROPE ENDOSCOPE REPROCESSING MARKET SIZE, BY SERVICE MODEL, 2025-2032 (USD MILLION)
  • TABLE 283. EUROPE ENDOSCOPE REPROCESSING MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 284. EUROPE ENDOSCOPE REPROCESSING MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 285. EUROPE ENDOSCOPE REPROCESSING MARKET SIZE, BY FLEXIBLE, 2018-2024 (USD MILLION)
  • TABLE 286. EUROPE ENDOSCOPE REPROCESSING MARKET SIZE, BY FLEXIBLE, 2025-2032 (USD MILLION)
  • TABLE 287. EUROPE ENDOSCOPE REPROCESSING MARKET SIZE, BY RIGID, 2018-2024 (USD MILLION)
  • TABLE 288. EUROPE ENDOSCOPE REPROCESSING MARKET SIZE, BY RIGID, 2025-2032 (USD MILLION)
  • TABLE 289. EUROPE ENDOSCOPE REPROCESSING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 290. EUROPE ENDOSCOPE REPROCESSING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 291. EUROPE ENDOSCOPE REPROCESSING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 292. EUROPE ENDOSCOPE REPROCESSING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 293. EUROPE ENDOSCOPE REPROCESSING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 294. EUROPE ENDOSCOPE REPROCESSING MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 295. EUROPE ENDOSCOPE REPROCESSING MARKET SIZE, BY CAPITAL EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 296. EUROPE ENDOSCOPE REPROCESSING MARKET SIZE, BY CAPITAL EQUIPMENT, 2025-2032 (USD MILLION)
  • TABLE 297. EUROPE ENDOSCOPE REPROCESSING MARKET SIZE, BY CONSUMABLES AND ACCESSORIES, 2018-2024 (USD MILLION)
  • TABLE 298. EUROPE ENDOSCOPE REPROCESSING MARKET SIZE, BY CONSUMABLES AND ACCESSORIES, 2025-2032 (USD MILLION)
  • TABLE 299. MIDDLE EAST ENDOSCOPE REPROCESSING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 300. MIDDLE EAST ENDOSCOPE REPROCESSING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 301. MIDDLE EAST ENDOSCOPE REPROCESSING MARKET SIZE, BY SERVICE MODEL, 2018-2024 (USD MILLION)
  • TABLE 302. MIDDLE EAST ENDOSCOPE REPROCESSING MARKET SIZE, BY SERVICE MODEL, 2025-2032 (USD MILLION)
  • TABLE 303. MIDDLE EAST ENDOSCOPE REPROCESSING MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 304. MIDDLE EAST ENDOSCOPE REPROCESSING MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 305. MIDDLE EAST ENDOSCOPE REPROCESSING MARKET SIZE, BY FLEXIBLE, 2018-2024 (USD MILLION)
  • TABLE 306. MIDDLE EAST ENDOSCOPE REPROCESSING MARKET SIZE, BY FLEXIBLE, 2025-2032 (USD MILLION)
  • TABLE 307. MIDDLE EAST ENDOSCOPE REPROCESSING MARKET SIZE, BY RIGID, 2018-2024 (USD MILLION)
  • TABLE 308. MIDDLE EAST ENDOSCOPE REPROCESSING MARKET SIZE, BY RIGID, 2025-2032 (USD MILLION)
  • TABLE 309. MIDDLE EAST ENDOSCOPE REPROCESSING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 310. MIDDLE EAST ENDOSCOPE REPROCESSING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 311. MIDDLE EAST ENDOSCOPE REPROCESSING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 312. MIDDLE EAST ENDOSCOPE REPROCESSING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 313. MIDDLE EAST ENDOSCOPE REPROCESSING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 314. MIDDLE EAST ENDOSCOPE REPROCESSING MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 315. MIDDLE EAST ENDOSCOPE REPROCESSING MARKET SIZE, BY CAPITAL EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 316. MIDDLE EAST ENDOSCOPE REPROCESSING MARKET SIZE, BY CAPITAL EQUIPMENT, 2025-2032 (